Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Hypertension, Pulmonary | 22 | 2023 | 1527 | 4.490 |
Why?
|
Bone Morphogenetic Proteins | 29 | 2021 | 838 | 4.430 |
Why?
|
Activin Receptors, Type I | 16 | 2022 | 142 | 2.540 |
Why?
|
Myositis Ossificans | 14 | 2022 | 79 | 2.490 |
Why?
|
Ossification, Heterotopic | 14 | 2022 | 239 | 2.410 |
Why?
|
Bone Morphogenetic Protein Receptors, Type I | 17 | 2020 | 96 | 2.120 |
Why?
|
Growth Differentiation Factor 2 | 6 | 2021 | 29 | 1.580 |
Why?
|
Bone Morphogenetic Protein Receptors, Type II | 7 | 2015 | 68 | 1.520 |
Why?
|
Pyrazoles | 18 | 2020 | 1970 | 1.170 |
Why?
|
Pyrimidines | 18 | 2020 | 2933 | 1.040 |
Why?
|
Signal Transduction | 35 | 2022 | 23387 | 0.970 |
Why?
|
Bone Morphogenetic Protein 6 | 4 | 2020 | 52 | 0.790 |
Why?
|
Activin Receptors, Type II | 3 | 2013 | 127 | 0.740 |
Why?
|
Hypertension, Portal | 2 | 2020 | 220 | 0.730 |
Why?
|
Connective Tissue Diseases | 1 | 2022 | 264 | 0.700 |
Why?
|
Endothelial Cells | 10 | 2023 | 3455 | 0.670 |
Why?
|
Dideoxynucleosides | 1 | 2018 | 122 | 0.630 |
Why?
|
Osteogenesis | 7 | 2023 | 1299 | 0.630 |
Why?
|
Disaccharides | 5 | 2005 | 172 | 0.610 |
Why?
|
Pulmonary Artery | 8 | 2023 | 1911 | 0.600 |
Why?
|
Elafin | 1 | 2015 | 33 | 0.530 |
Why?
|
Lipoproteins, LDL | 2 | 2015 | 628 | 0.500 |
Why?
|
Smad Proteins | 6 | 2019 | 162 | 0.490 |
Why?
|
Protein Kinase Inhibitors | 7 | 2019 | 5522 | 0.470 |
Why?
|
Aminopyridines | 2 | 2014 | 541 | 0.460 |
Why?
|
Caveolin 1 | 1 | 2015 | 264 | 0.460 |
Why?
|
Transforming Growth Factor beta | 4 | 2016 | 2006 | 0.450 |
Why?
|
Quinolines | 2 | 2020 | 719 | 0.440 |
Why?
|
Bone Morphogenetic Protein 7 | 4 | 2020 | 112 | 0.440 |
Why?
|
Small Molecule Libraries | 2 | 2009 | 721 | 0.440 |
Why?
|
Cell Differentiation | 10 | 2020 | 11470 | 0.440 |
Why?
|
Microvessels | 4 | 2023 | 544 | 0.430 |
Why?
|
Activins | 3 | 2020 | 208 | 0.420 |
Why?
|
Bone Morphogenetic Protein 2 | 4 | 2021 | 350 | 0.400 |
Why?
|
Benzodioxoles | 2 | 2022 | 69 | 0.400 |
Why?
|
Lung | 7 | 2023 | 9826 | 0.400 |
Why?
|
Protease Inhibitors | 1 | 2015 | 790 | 0.390 |
Why?
|
Basic Helix-Loop-Helix Transcription Factors | 1 | 2016 | 1114 | 0.380 |
Why?
|
Bone Morphogenetic Protein Receptors | 4 | 2023 | 47 | 0.370 |
Why?
|
Liver Diseases | 1 | 2019 | 1252 | 0.370 |
Why?
|
Animals | 65 | 2023 | 168561 | 0.370 |
Why?
|
Vascular Diseases | 1 | 2018 | 1155 | 0.350 |
Why?
|
Muscle, Smooth, Vascular | 3 | 2016 | 1504 | 0.350 |
Why?
|
Zebrafish | 6 | 2021 | 2990 | 0.330 |
Why?
|
Anemia | 3 | 2015 | 1499 | 0.330 |
Why?
|
Adaptor Proteins, Signal Transducing | 5 | 2021 | 2915 | 0.330 |
Why?
|
Ligands | 8 | 2022 | 3293 | 0.330 |
Why?
|
Immunoglobulin M | 4 | 2005 | 1538 | 0.320 |
Why?
|
Cell Physiological Phenomena | 1 | 2009 | 154 | 0.320 |
Why?
|
Smad1 Protein | 4 | 2014 | 81 | 0.310 |
Why?
|
Mice | 42 | 2023 | 81045 | 0.310 |
Why?
|
Bone Morphogenetic Protein 4 | 4 | 2020 | 162 | 0.290 |
Why?
|
Stem Cells | 3 | 2017 | 3563 | 0.290 |
Why?
|
Bone Diseases | 1 | 2009 | 416 | 0.270 |
Why?
|
Bone Marrow | 1 | 2016 | 2941 | 0.270 |
Why?
|
Inflammation | 7 | 2022 | 10578 | 0.260 |
Why?
|
Cardiovascular Agents | 1 | 2012 | 848 | 0.260 |
Why?
|
Antimicrobial Cationic Peptides | 4 | 2012 | 362 | 0.250 |
Why?
|
Quinazolines | 2 | 2022 | 1355 | 0.250 |
Why?
|
Humans | 78 | 2023 | 742088 | 0.250 |
Why?
|
Mice, Inbred C57BL | 14 | 2021 | 21821 | 0.250 |
Why?
|
Hep G2 Cells | 4 | 2014 | 392 | 0.240 |
Why?
|
Phosphorylation | 9 | 2020 | 8436 | 0.230 |
Why?
|
Core Binding Factor Alpha 1 Subunit | 2 | 2023 | 164 | 0.230 |
Why?
|
Mice, Transgenic | 9 | 2021 | 9735 | 0.220 |
Why?
|
Mutation | 12 | 2022 | 29717 | 0.220 |
Why?
|
Atherosclerosis | 3 | 2023 | 3428 | 0.220 |
Why?
|
Osteoblasts | 5 | 2020 | 1163 | 0.220 |
Why?
|
Immunoglobulin G | 4 | 2005 | 4554 | 0.210 |
Why?
|
Immunoglobulin Heavy Chains | 1 | 2005 | 659 | 0.210 |
Why?
|
Recombinant Fusion Proteins | 4 | 2022 | 3770 | 0.210 |
Why?
|
Gene Knock-In Techniques | 3 | 2021 | 418 | 0.200 |
Why?
|
Rats | 10 | 2022 | 24265 | 0.200 |
Why?
|
Wounds and Injuries | 3 | 2020 | 2400 | 0.200 |
Why?
|
Antigens, Heterophile | 2 | 1999 | 69 | 0.200 |
Why?
|
Cell Division | 2 | 2015 | 4564 | 0.200 |
Why?
|
Osteochondrodysplasias | 1 | 2022 | 183 | 0.200 |
Why?
|
Structure-Activity Relationship | 4 | 2018 | 3133 | 0.200 |
Why?
|
Skin Diseases, Genetic | 1 | 2021 | 40 | 0.190 |
Why?
|
Myocytes, Smooth Muscle | 1 | 2005 | 686 | 0.190 |
Why?
|
Vascular Endothelial Growth Factor Receptor-2 | 1 | 2023 | 544 | 0.190 |
Why?
|
Hepatopulmonary Syndrome | 1 | 2020 | 20 | 0.190 |
Why?
|
Iron | 2 | 2014 | 1773 | 0.190 |
Why?
|
Cell Line | 9 | 2020 | 15994 | 0.180 |
Why?
|
Unfolded Protein Response | 1 | 2022 | 230 | 0.180 |
Why?
|
Phenols | 2 | 2014 | 501 | 0.180 |
Why?
|
Transplantation, Heterologous | 3 | 2005 | 2382 | 0.180 |
Why?
|
Endotoxemia | 1 | 2021 | 206 | 0.180 |
Why?
|
Disease Models, Animal | 8 | 2022 | 18006 | 0.180 |
Why?
|
Muscles | 2 | 2022 | 1617 | 0.170 |
Why?
|
Immunoglobulin Fc Fragments | 2 | 2020 | 279 | 0.170 |
Why?
|
Pulmonary Wedge Pressure | 1 | 2019 | 264 | 0.160 |
Why?
|
Salivary Glands | 1 | 2020 | 228 | 0.160 |
Why?
|
Endothelium | 1 | 2021 | 778 | 0.160 |
Why?
|
Laboratory Personnel | 1 | 2018 | 19 | 0.160 |
Why?
|
Complement Activation | 2 | 1999 | 452 | 0.160 |
Why?
|
Mice, Knockout | 9 | 2023 | 14554 | 0.160 |
Why?
|
Collagen Type III | 1 | 2018 | 90 | 0.160 |
Why?
|
Sjogren's Syndrome | 1 | 2020 | 229 | 0.160 |
Why?
|
Vascular Endothelial Growth Factor A | 3 | 2023 | 3502 | 0.160 |
Why?
|
Lung Injury | 1 | 2023 | 436 | 0.160 |
Why?
|
Vascular Resistance | 2 | 2019 | 936 | 0.160 |
Why?
|
Sarcoma, Synovial | 1 | 2019 | 164 | 0.160 |
Why?
|
Antibody Specificity | 4 | 2005 | 1094 | 0.160 |
Why?
|
Chloride Channels | 1 | 2019 | 225 | 0.150 |
Why?
|
Retinal Diseases | 1 | 2023 | 683 | 0.150 |
Why?
|
Acute Lung Injury | 1 | 2021 | 378 | 0.150 |
Why?
|
Gene Expression Regulation | 6 | 2019 | 12071 | 0.150 |
Why?
|
Bone Diseases, Metabolic | 1 | 2021 | 417 | 0.150 |
Why?
|
Heart | 2 | 2023 | 4462 | 0.150 |
Why?
|
Pro-Opiomelanocortin | 1 | 2017 | 163 | 0.150 |
Why?
|
Hedgehog Proteins | 1 | 2021 | 781 | 0.140 |
Why?
|
Ligaments | 1 | 2016 | 127 | 0.140 |
Why?
|
End Stage Liver Disease | 1 | 2020 | 314 | 0.140 |
Why?
|
Rats, Sprague-Dawley | 5 | 2020 | 8300 | 0.140 |
Why?
|
Heart Neoplasms | 1 | 2019 | 374 | 0.130 |
Why?
|
Ventricular Function, Right | 1 | 2019 | 592 | 0.130 |
Why?
|
Career Mobility | 1 | 2018 | 262 | 0.130 |
Why?
|
Turpentine | 2 | 2014 | 11 | 0.130 |
Why?
|
Intercellular Signaling Peptides and Proteins | 2 | 2015 | 1675 | 0.130 |
Why?
|
Cardiomyopathy, Dilated | 1 | 2022 | 851 | 0.130 |
Why?
|
Phosphoproteins | 2 | 2018 | 2440 | 0.130 |
Why?
|
RNA, Small Interfering | 3 | 2013 | 3504 | 0.130 |
Why?
|
Interleukin-6 | 3 | 2020 | 3199 | 0.130 |
Why?
|
Endocrinology | 1 | 2021 | 443 | 0.130 |
Why?
|
Receptors, Transforming Growth Factor beta | 1 | 2016 | 314 | 0.130 |
Why?
|
Joints | 1 | 2016 | 326 | 0.130 |
Why?
|
p38 Mitogen-Activated Protein Kinases | 2 | 2010 | 697 | 0.130 |
Why?
|
Recombinant Proteins | 2 | 2016 | 6608 | 0.120 |
Why?
|
Gene Deletion | 3 | 2020 | 2751 | 0.120 |
Why?
|
Gene Targeting | 1 | 2017 | 880 | 0.120 |
Why?
|
Matrix Metalloproteinases, Secreted | 2 | 2014 | 14 | 0.120 |
Why?
|
Immunoconjugates | 1 | 2020 | 897 | 0.110 |
Why?
|
Coronary Stenosis | 1 | 2019 | 834 | 0.110 |
Why?
|
Cell Separation | 1 | 2019 | 1749 | 0.110 |
Why?
|
Liver Regeneration | 1 | 2014 | 210 | 0.110 |
Why?
|
Smad5 Protein | 2 | 2012 | 27 | 0.110 |
Why?
|
Carrier Proteins | 2 | 2020 | 5019 | 0.110 |
Why?
|
Lower Extremity | 1 | 2020 | 1151 | 0.110 |
Why?
|
Smad7 Protein | 2 | 2009 | 41 | 0.110 |
Why?
|
Phosphoprotein Phosphatases | 1 | 2014 | 337 | 0.110 |
Why?
|
Molecular Structure | 3 | 2018 | 1907 | 0.100 |
Why?
|
Cells, Cultured | 7 | 2016 | 19223 | 0.100 |
Why?
|
Transcription, Genetic | 6 | 2020 | 7721 | 0.100 |
Why?
|
Fetal Growth Retardation | 1 | 2015 | 570 | 0.100 |
Why?
|
Membrane Proteins | 3 | 2015 | 7873 | 0.100 |
Why?
|
Heterozygote | 3 | 2021 | 2790 | 0.100 |
Why?
|
Fibrosis | 1 | 2018 | 2026 | 0.100 |
Why?
|
Aldosterone | 1 | 2016 | 876 | 0.100 |
Why?
|
Neural Crest | 1 | 2013 | 275 | 0.100 |
Why?
|
Alleles | 2 | 2016 | 6931 | 0.090 |
Why?
|
Autoantibodies | 1 | 1999 | 2036 | 0.090 |
Why?
|
Extracellular Matrix Proteins | 1 | 2015 | 849 | 0.090 |
Why?
|
Pulmonary Circulation | 2 | 2022 | 739 | 0.090 |
Why?
|
Biocompatible Materials | 1 | 2019 | 1731 | 0.090 |
Why?
|
Retina | 1 | 2021 | 2611 | 0.090 |
Why?
|
Male | 25 | 2023 | 349538 | 0.090 |
Why?
|
Calcium-Binding Proteins | 1 | 2015 | 1081 | 0.090 |
Why?
|
Induced Pluripotent Stem Cells | 1 | 2021 | 1728 | 0.090 |
Why?
|
Up-Regulation | 2 | 2016 | 4211 | 0.090 |
Why?
|
Cell Lineage | 2 | 2016 | 2504 | 0.090 |
Why?
|
Protein Binding | 6 | 2018 | 9387 | 0.090 |
Why?
|
Multiprotein Complexes | 1 | 2016 | 1119 | 0.090 |
Why?
|
Cattle | 1 | 2015 | 3923 | 0.090 |
Why?
|
Cardiac Tamponade | 1 | 2010 | 173 | 0.090 |
Why?
|
Iron Overload | 1 | 2011 | 243 | 0.090 |
Why?
|
Receptors, LDL | 1 | 2012 | 475 | 0.090 |
Why?
|
Transcription Factors | 2 | 2023 | 12164 | 0.090 |
Why?
|
Craniosynostoses | 1 | 2013 | 400 | 0.080 |
Why?
|
Sulfonamides | 1 | 2018 | 1932 | 0.080 |
Why?
|
Takotsubo Cardiomyopathy | 1 | 2010 | 125 | 0.080 |
Why?
|
Hemodynamics | 2 | 2016 | 4197 | 0.080 |
Why?
|
Pericardial Effusion | 1 | 2010 | 246 | 0.080 |
Why?
|
Antibodies, Heterophile | 2 | 1999 | 126 | 0.080 |
Why?
|
Bone Marrow Cells | 1 | 2016 | 2513 | 0.080 |
Why?
|
Heart Failure | 2 | 2022 | 10856 | 0.080 |
Why?
|
Bone Marrow Transplantation | 1 | 2016 | 2763 | 0.080 |
Why?
|
B-Lymphocyte Subsets | 2 | 2001 | 246 | 0.080 |
Why?
|
Female | 21 | 2021 | 379592 | 0.080 |
Why?
|
Histocompatibility Antigens Class I | 1 | 2014 | 1366 | 0.080 |
Why?
|
Critical Care | 1 | 2020 | 2640 | 0.080 |
Why?
|
Calcinosis | 1 | 2016 | 1497 | 0.070 |
Why?
|
Cell Proliferation | 3 | 2018 | 10472 | 0.070 |
Why?
|
Liver | 2 | 2014 | 7470 | 0.070 |
Why?
|
Sepsis | 1 | 2021 | 2589 | 0.070 |
Why?
|
Esophageal Fistula | 1 | 2007 | 64 | 0.070 |
Why?
|
Cardiology | 1 | 2018 | 1658 | 0.070 |
Why?
|
TOR Serine-Threonine Kinases | 1 | 2016 | 2107 | 0.070 |
Why?
|
Myocytes, Cardiac | 2 | 2022 | 1636 | 0.070 |
Why?
|
Anti-Inflammatory Agents | 2 | 2017 | 1788 | 0.070 |
Why?
|
Energy Metabolism | 1 | 2017 | 2896 | 0.070 |
Why?
|
Protein Processing, Post-Translational | 1 | 2014 | 1989 | 0.070 |
Why?
|
Embryo, Nonmammalian | 1 | 2009 | 894 | 0.070 |
Why?
|
Swine | 5 | 2005 | 5934 | 0.070 |
Why?
|
Genetic Testing | 1 | 2019 | 3439 | 0.070 |
Why?
|
Protein Structure, Tertiary | 1 | 2013 | 3847 | 0.070 |
Why?
|
Wnt Proteins | 1 | 2010 | 721 | 0.070 |
Why?
|
Immunity, Innate | 2 | 1999 | 2956 | 0.070 |
Why?
|
Blotting, Western | 4 | 2016 | 5180 | 0.070 |
Why?
|
Fatty Liver | 1 | 2012 | 728 | 0.070 |
Why?
|
Trisaccharides | 1 | 2005 | 50 | 0.070 |
Why?
|
Carbohydrate Conformation | 1 | 2005 | 208 | 0.070 |
Why?
|
Hepatitis C | 1 | 2015 | 1582 | 0.060 |
Why?
|
Computer Simulation | 1 | 2019 | 6191 | 0.060 |
Why?
|
Immunoprecipitation | 1 | 2007 | 905 | 0.060 |
Why?
|
Carbohydrate Sequence | 1 | 2005 | 414 | 0.060 |
Why?
|
Lipopolysaccharides | 1 | 2012 | 2211 | 0.060 |
Why?
|
Neoplastic Stem Cells | 1 | 2012 | 1376 | 0.060 |
Why?
|
Hepatocytes | 1 | 2011 | 1209 | 0.060 |
Why?
|
Zebrafish Proteins | 1 | 2011 | 1004 | 0.060 |
Why?
|
Cardiovascular Diseases | 2 | 2023 | 15108 | 0.060 |
Why?
|
Immunoglobulin Variable Region | 1 | 2005 | 421 | 0.060 |
Why?
|
Reactive Oxygen Species | 1 | 2012 | 2077 | 0.060 |
Why?
|
RNA Interference | 1 | 2013 | 2890 | 0.060 |
Why?
|
Inhibitor of Differentiation Protein 1 | 2 | 2014 | 47 | 0.060 |
Why?
|
Middle Aged | 12 | 2022 | 213127 | 0.060 |
Why?
|
Eosinophil Granule Proteins | 1 | 2023 | 30 | 0.060 |
Why?
|
Antioxidants | 1 | 2012 | 1659 | 0.060 |
Why?
|
Atrial Appendage | 1 | 2007 | 282 | 0.060 |
Why?
|
DNA Primers | 1 | 2007 | 2892 | 0.060 |
Why?
|
Phenotype | 2 | 2020 | 16331 | 0.060 |
Why?
|
Adult | 11 | 2022 | 213712 | 0.060 |
Why?
|
Models, Biological | 3 | 2009 | 9581 | 0.050 |
Why?
|
Ribonucleases | 1 | 2023 | 287 | 0.050 |
Why?
|
Tumor Suppressor Proteins | 1 | 2012 | 2842 | 0.050 |
Why?
|
Positron-Emission Tomography | 1 | 2018 | 6259 | 0.050 |
Why?
|
Cholesterol, LDL | 1 | 2012 | 2354 | 0.050 |
Why?
|
Xenon Isotopes | 1 | 2022 | 65 | 0.050 |
Why?
|
Coronavirus Infections | 1 | 2020 | 3130 | 0.050 |
Why?
|
Macrophages | 2 | 2017 | 5655 | 0.050 |
Why?
|
Pneumonia, Viral | 1 | 2020 | 3236 | 0.050 |
Why?
|
Genotype | 1 | 2016 | 12946 | 0.050 |
Why?
|
Myography | 1 | 2022 | 109 | 0.050 |
Why?
|
Cell Membrane | 2 | 2005 | 3744 | 0.050 |
Why?
|
Proto-Oncogene Proteins c-akt | 1 | 2010 | 2502 | 0.050 |
Why?
|
Dinitrobenzenes | 1 | 2001 | 37 | 0.050 |
Why?
|
Mutation, Missense | 3 | 2020 | 2556 | 0.050 |
Why?
|
Ovalbumin | 1 | 2023 | 719 | 0.050 |
Why?
|
Biology | 1 | 2023 | 292 | 0.050 |
Why?
|
Interleukin-13 | 1 | 2023 | 389 | 0.050 |
Why?
|
Pulmonary Veins | 1 | 2007 | 759 | 0.050 |
Why?
|
Cardiac Imaging Techniques | 1 | 2023 | 269 | 0.050 |
Why?
|
Fluorescent Antibody Technique | 2 | 2016 | 2505 | 0.050 |
Why?
|
Haptens | 1 | 2001 | 166 | 0.050 |
Why?
|
Embryonic Stem Cells | 1 | 2008 | 1294 | 0.050 |
Why?
|
Cleidocranial Dysplasia | 1 | 2020 | 19 | 0.050 |
Why?
|
Smad Proteins, Receptor-Regulated | 1 | 2020 | 9 | 0.050 |
Why?
|
Epithelial Cells | 1 | 2012 | 3678 | 0.050 |
Why?
|
Vasoconstriction | 1 | 2023 | 596 | 0.050 |
Why?
|
Oxidative Stress | 2 | 2022 | 3081 | 0.050 |
Why?
|
Antigens, CD20 | 1 | 2001 | 198 | 0.050 |
Why?
|
Galactosides | 1 | 1999 | 50 | 0.040 |
Why?
|
Physicians | 1 | 2018 | 4554 | 0.040 |
Why?
|
Sequence Deletion | 1 | 2004 | 1526 | 0.040 |
Why?
|
Casein Kinase II | 1 | 2020 | 128 | 0.040 |
Why?
|
COS Cells | 2 | 2014 | 1160 | 0.040 |
Why?
|
Patient Isolation | 1 | 2020 | 100 | 0.040 |
Why?
|
Complement Fixation Tests | 1 | 1999 | 78 | 0.040 |
Why?
|
Alanine | 1 | 2022 | 572 | 0.040 |
Why?
|
Respiratory Therapy | 1 | 2020 | 132 | 0.040 |
Why?
|
Antibodies, Anti-Idiotypic | 1 | 2001 | 349 | 0.040 |
Why?
|
MicroRNAs | 1 | 2015 | 3731 | 0.040 |
Why?
|
Trans-Activators | 1 | 2009 | 2924 | 0.040 |
Why?
|
Amino Acid Motifs | 2 | 2014 | 936 | 0.040 |
Why?
|
GTP-Binding Protein alpha Subunits, Gs | 1 | 2021 | 202 | 0.040 |
Why?
|
Expert Testimony | 1 | 2021 | 356 | 0.040 |
Why?
|
Vasodilation | 1 | 2023 | 944 | 0.040 |
Why?
|
Electric Impedance | 1 | 2022 | 727 | 0.040 |
Why?
|
X-Ray Microtomography | 1 | 2020 | 428 | 0.040 |
Why?
|
Extracorporeal Circulation | 1 | 1999 | 182 | 0.040 |
Why?
|
Smoking | 1 | 2015 | 8969 | 0.040 |
Why?
|
Eosinophils | 1 | 2023 | 953 | 0.040 |
Why?
|
Time Management | 1 | 2018 | 50 | 0.040 |
Why?
|
Hemorrhage | 1 | 2010 | 3461 | 0.040 |
Why?
|
Case-Control Studies | 3 | 2021 | 21719 | 0.040 |
Why?
|
Neutralization Tests | 1 | 2020 | 758 | 0.040 |
Why?
|
Hematopoietic Stem Cells | 1 | 2011 | 3381 | 0.040 |
Why?
|
Protein Stability | 1 | 2020 | 556 | 0.040 |
Why?
|
Antibody Affinity | 1 | 1999 | 253 | 0.040 |
Why?
|
Blood Proteins | 1 | 2023 | 1122 | 0.040 |
Why?
|
Hydrogen Peroxide | 1 | 2022 | 730 | 0.040 |
Why?
|
Neurons | 1 | 2017 | 9325 | 0.040 |
Why?
|
Haploinsufficiency | 1 | 2020 | 329 | 0.040 |
Why?
|
Pulmonary Edema | 1 | 2021 | 415 | 0.040 |
Why?
|
Hindlimb | 1 | 2020 | 505 | 0.040 |
Why?
|
Smad3 Protein | 1 | 2018 | 180 | 0.040 |
Why?
|
Piperazines | 1 | 2008 | 2488 | 0.040 |
Why?
|
RNA, Messenger | 3 | 2020 | 13029 | 0.040 |
Why?
|
Appetite Regulation | 1 | 2017 | 88 | 0.040 |
Why?
|
Infectious Disease Transmission, Patient-to-Professional | 1 | 2020 | 253 | 0.040 |
Why?
|
Glycoproteins | 2 | 2010 | 2260 | 0.040 |
Why?
|
Blast Injuries | 1 | 2020 | 302 | 0.040 |
Why?
|
Multicenter Studies as Topic | 1 | 2022 | 1661 | 0.040 |
Why?
|
Homeostasis | 2 | 2020 | 3335 | 0.040 |
Why?
|
Transfection | 1 | 2005 | 5892 | 0.040 |
Why?
|
Liver Failure | 1 | 1999 | 240 | 0.040 |
Why?
|
Congresses as Topic | 1 | 2021 | 764 | 0.040 |
Why?
|
Dependovirus | 1 | 2022 | 706 | 0.040 |
Why?
|
Dose-Response Relationship, Drug | 2 | 2009 | 10943 | 0.040 |
Why?
|
Amino Acid Substitution | 2 | 2014 | 1792 | 0.040 |
Why?
|
Virulence | 1 | 2020 | 1328 | 0.030 |
Why?
|
Base Sequence | 1 | 2007 | 12797 | 0.030 |
Why?
|
Ribosomal Protein S6 Kinases, 70-kDa | 1 | 2016 | 104 | 0.030 |
Why?
|
Antibody Formation | 1 | 2001 | 1402 | 0.030 |
Why?
|
Tacrolimus Binding Protein 1A | 1 | 2015 | 38 | 0.030 |
Why?
|
Antigens, Differentiation | 1 | 2019 | 926 | 0.030 |
Why?
|
Monocrotaline | 1 | 2015 | 26 | 0.030 |
Why?
|
Amino Acids | 1 | 2022 | 1727 | 0.030 |
Why?
|
Saliva | 1 | 2020 | 805 | 0.030 |
Why?
|
Drug Evaluation, Preclinical | 1 | 2021 | 1372 | 0.030 |
Why?
|
History, 21st Century | 1 | 2021 | 1533 | 0.030 |
Why?
|
Cell Line, Tumor | 2 | 2012 | 16665 | 0.030 |
Why?
|
Densitometry | 1 | 2015 | 156 | 0.030 |
Why?
|
Binding, Competitive | 1 | 1996 | 1159 | 0.030 |
Why?
|
RNA | 1 | 2005 | 2747 | 0.030 |
Why?
|
Irritants | 1 | 2014 | 43 | 0.030 |
Why?
|
Tomography, X-Ray Computed | 2 | 2008 | 20086 | 0.030 |
Why?
|
Systems Biology | 1 | 2018 | 469 | 0.030 |
Why?
|
Diabetes Mellitus, Experimental | 1 | 2021 | 1121 | 0.030 |
Why?
|
Nitric Oxide | 1 | 2023 | 2128 | 0.030 |
Why?
|
Gene Knockout Techniques | 1 | 2017 | 808 | 0.030 |
Why?
|
Protein Transport | 1 | 2020 | 1988 | 0.030 |
Why?
|
Young Adult | 4 | 2022 | 56350 | 0.030 |
Why?
|
Trophoblasts | 1 | 2015 | 215 | 0.030 |
Why?
|
Immunologic Memory | 1 | 2001 | 1348 | 0.030 |
Why?
|
Nerve Tissue Proteins | 1 | 2007 | 4465 | 0.030 |
Why?
|
Biological Availability | 1 | 2014 | 396 | 0.030 |
Why?
|
Antibodies | 1 | 2022 | 2459 | 0.030 |
Why?
|
Research Support as Topic | 1 | 2018 | 704 | 0.030 |
Why?
|
Occupational Health | 1 | 2020 | 809 | 0.030 |
Why?
|
Thermogenesis | 1 | 2017 | 429 | 0.030 |
Why?
|
Immunologic Deficiency Syndromes | 1 | 1997 | 546 | 0.030 |
Why?
|
JNK Mitogen-Activated Protein Kinases | 1 | 2015 | 452 | 0.030 |
Why?
|
Maternal-Fetal Exchange | 1 | 2015 | 455 | 0.030 |
Why?
|
Cell Membrane Permeability | 1 | 2015 | 590 | 0.030 |
Why?
|
Smad8 Protein | 1 | 2012 | 17 | 0.030 |
Why?
|
Sulfoxides | 1 | 2012 | 48 | 0.030 |
Why?
|
Mentors | 1 | 2018 | 630 | 0.030 |
Why?
|
Retinal Dehydrogenase | 1 | 2012 | 74 | 0.030 |
Why?
|
Infant, Small for Gestational Age | 1 | 2015 | 440 | 0.030 |
Why?
|
Systole | 1 | 2015 | 956 | 0.030 |
Why?
|
Self Care | 1 | 2018 | 786 | 0.030 |
Why?
|
Drug-Eluting Stents | 1 | 2019 | 753 | 0.030 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 1 | 2019 | 3862 | 0.030 |
Why?
|
Carbon Monoxide | 1 | 2015 | 531 | 0.030 |
Why?
|
Species Specificity | 1 | 1996 | 2479 | 0.030 |
Why?
|
Cell Cycle Proteins | 1 | 2023 | 3444 | 0.030 |
Why?
|
Hypothalamus | 1 | 2017 | 1063 | 0.030 |
Why?
|
Catalytic Domain | 1 | 2014 | 699 | 0.030 |
Why?
|
Oxygen | 1 | 2023 | 4169 | 0.030 |
Why?
|
Physicians, Women | 1 | 2018 | 487 | 0.030 |
Why?
|
Immunoblotting | 1 | 2015 | 1683 | 0.030 |
Why?
|
Molecular Conformation | 1 | 2013 | 563 | 0.030 |
Why?
|
Diabetic Retinopathy | 1 | 2021 | 1205 | 0.030 |
Why?
|
Adipose Tissue, Brown | 1 | 2017 | 754 | 0.030 |
Why?
|
Angioplasty, Balloon, Coronary | 1 | 2019 | 1873 | 0.030 |
Why?
|
DNA Copy Number Variations | 1 | 2020 | 1940 | 0.020 |
Why?
|
Adenoviridae | 1 | 2015 | 1096 | 0.020 |
Why?
|
Aged | 5 | 2022 | 162944 | 0.020 |
Why?
|
Mesoderm | 1 | 2014 | 686 | 0.020 |
Why?
|
Mammals | 1 | 1996 | 1135 | 0.020 |
Why?
|
Endothelium, Vascular | 2 | 2020 | 4455 | 0.020 |
Why?
|
Prefrontal Cortex | 1 | 2021 | 2146 | 0.020 |
Why?
|
Tissue Distribution | 1 | 2014 | 2335 | 0.020 |
Why?
|
Drug Discovery | 1 | 2018 | 1057 | 0.020 |
Why?
|
RNA Polymerase II | 1 | 2014 | 550 | 0.020 |
Why?
|
Mesenchymal Stem Cells | 1 | 2020 | 1625 | 0.020 |
Why?
|
Aortic Diseases | 1 | 2016 | 741 | 0.020 |
Why?
|
Time Factors | 1 | 2012 | 40054 | 0.020 |
Why?
|
Occupational Exposure | 1 | 2020 | 1794 | 0.020 |
Why?
|
Recovery of Function | 1 | 2020 | 2924 | 0.020 |
Why?
|
Ubiquitination | 1 | 2014 | 1011 | 0.020 |
Why?
|
Binding Sites | 1 | 2018 | 6115 | 0.020 |
Why?
|
Burns | 1 | 2020 | 1809 | 0.020 |
Why?
|
Burnout, Professional | 1 | 2018 | 690 | 0.020 |
Why?
|
Apoptosis | 2 | 2016 | 9715 | 0.020 |
Why?
|
HIV Infections | 1 | 2015 | 16678 | 0.020 |
Why?
|
Liver Transplantation | 1 | 2020 | 2117 | 0.020 |
Why?
|
Body Patterning | 1 | 2013 | 626 | 0.020 |
Why?
|
Nuclear Proteins | 1 | 2023 | 5851 | 0.020 |
Why?
|
Atrial Fibrillation | 1 | 2007 | 5019 | 0.020 |
Why?
|
Double-Blind Method | 1 | 2022 | 12017 | 0.020 |
Why?
|
Combinatorial Chemistry Techniques | 1 | 2008 | 129 | 0.020 |
Why?
|
Mice, Mutant Strains | 1 | 2011 | 1866 | 0.020 |
Why?
|
Isoenzymes | 1 | 2012 | 1725 | 0.020 |
Why?
|
Immunosuppressive Agents | 1 | 2001 | 4147 | 0.020 |
Why?
|
Antiviral Agents | 1 | 2020 | 2978 | 0.020 |
Why?
|
Proteasome Endopeptidase Complex | 1 | 2014 | 1333 | 0.020 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2014 | 4751 | 0.020 |
Why?
|
Tetrazoles | 1 | 2012 | 835 | 0.020 |
Why?
|
Gestational Age | 1 | 2015 | 3490 | 0.020 |
Why?
|
Granulosa Cells | 1 | 2007 | 120 | 0.020 |
Why?
|
Child, Hospitalized | 1 | 2008 | 174 | 0.020 |
Why?
|
Administration, Oral | 1 | 2014 | 3913 | 0.020 |
Why?
|
Polymerase Chain Reaction | 1 | 2016 | 6171 | 0.020 |
Why?
|
Placenta | 1 | 2015 | 1694 | 0.020 |
Why?
|
Diabetes Mellitus, Type 1 | 1 | 2021 | 3336 | 0.020 |
Why?
|
Wound Healing | 1 | 2017 | 2781 | 0.020 |
Why?
|
Sex Factors | 1 | 2020 | 10392 | 0.020 |
Why?
|
GPI-Linked Proteins | 1 | 2007 | 434 | 0.020 |
Why?
|
Cell Survival | 1 | 2016 | 5872 | 0.020 |
Why?
|
Genetic Vectors | 1 | 2015 | 3420 | 0.020 |
Why?
|
Neovascularization, Physiologic | 1 | 2013 | 1350 | 0.020 |
Why?
|
Pain | 1 | 2021 | 4961 | 0.020 |
Why?
|
Adolescent | 3 | 2022 | 85649 | 0.020 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2022 | 9941 | 0.020 |
Why?
|
Keratinocytes | 1 | 2009 | 797 | 0.020 |
Why?
|
Breast Neoplasms | 1 | 2012 | 20774 | 0.020 |
Why?
|
Neutrophils | 1 | 2017 | 3711 | 0.020 |
Why?
|
Anemia, Iron-Deficiency | 1 | 2008 | 364 | 0.010 |
Why?
|
Gene Expression Regulation, Developmental | 1 | 2015 | 3617 | 0.010 |
Why?
|
NF-kappa B | 1 | 2012 | 2500 | 0.010 |
Why?
|
Antibodies, Monoclonal | 1 | 2001 | 9274 | 0.010 |
Why?
|
Arterioles | 1 | 2004 | 253 | 0.010 |
Why?
|
Evidence-Based Medicine | 1 | 2015 | 3611 | 0.010 |
Why?
|
Genetic Markers | 1 | 2010 | 2633 | 0.010 |
Why?
|
Treatment Outcome | 2 | 2020 | 62966 | 0.010 |
Why?
|
Child | 3 | 2022 | 77478 | 0.010 |
Why?
|
Image Interpretation, Computer-Assisted | 1 | 2016 | 3328 | 0.010 |
Why?
|
Muscle, Smooth | 1 | 2007 | 933 | 0.010 |
Why?
|
Heart Ventricles | 1 | 2015 | 3801 | 0.010 |
Why?
|
Models, Molecular | 1 | 2013 | 5454 | 0.010 |
Why?
|
Hemoglobins | 1 | 2008 | 1532 | 0.010 |
Why?
|
Blood Transfusion | 1 | 2008 | 1296 | 0.010 |
Why?
|
Gene Expression | 1 | 2014 | 7790 | 0.010 |
Why?
|
Viscosity | 1 | 2001 | 328 | 0.010 |
Why?
|
Urban Population | 1 | 2008 | 2018 | 0.010 |
Why?
|
Glycocalyx | 1 | 2001 | 88 | 0.010 |
Why?
|
Pandemics | 1 | 2020 | 8328 | 0.010 |
Why?
|
Immunization Schedule | 1 | 2001 | 221 | 0.010 |
Why?
|
Isomerism | 1 | 1999 | 201 | 0.010 |
Why?
|
Ventricular Dysfunction, Left | 1 | 2010 | 2059 | 0.010 |
Why?
|
Papio | 1 | 2001 | 656 | 0.010 |
Why?
|
Kinetics | 1 | 2007 | 6474 | 0.010 |
Why?
|
Immunoglobulin Class Switching | 1 | 2001 | 291 | 0.010 |
Why?
|
Gene Expression Profiling | 1 | 2015 | 9410 | 0.010 |
Why?
|
Risk Assessment | 1 | 2020 | 23320 | 0.010 |
Why?
|
Exons | 1 | 2004 | 2431 | 0.010 |
Why?
|
Antigens, CD19 | 1 | 2001 | 379 | 0.010 |
Why?
|
Antibodies, Monoclonal, Murine-Derived | 1 | 2001 | 694 | 0.010 |
Why?
|
Hemagglutinins | 1 | 1997 | 117 | 0.010 |
Why?
|
Electrocardiography | 1 | 2010 | 6440 | 0.010 |
Why?
|
Wiskott-Aldrich Syndrome | 1 | 1997 | 131 | 0.010 |
Why?
|
Immunization | 1 | 2001 | 1255 | 0.010 |
Why?
|
Aging | 1 | 2015 | 8626 | 0.010 |
Why?
|
DiGeorge Syndrome | 1 | 1997 | 177 | 0.010 |
Why?
|
Genetic Predisposition to Disease | 1 | 2017 | 17400 | 0.010 |
Why?
|
Infant, Newborn | 1 | 2015 | 25575 | 0.010 |
Why?
|
Obesity | 1 | 2017 | 12705 | 0.010 |
Why?
|
Severe Combined Immunodeficiency | 1 | 1997 | 221 | 0.010 |
Why?
|
Temperature | 1 | 2001 | 2207 | 0.010 |
Why?
|
Epitopes | 1 | 2001 | 2569 | 0.010 |
Why?
|
Pregnancy | 1 | 2015 | 29087 | 0.010 |
Why?
|
Risk Factors | 1 | 2020 | 72145 | 0.010 |
Why?
|
Infant | 2 | 2008 | 35070 | 0.010 |
Why?
|
Aorta | 1 | 1999 | 2057 | 0.010 |
Why?
|
Child, Preschool | 2 | 2008 | 40955 | 0.010 |
Why?
|
Retrospective Studies | 1 | 2019 | 77098 | 0.010 |
Why?
|
Flow Cytometry | 1 | 2001 | 5975 | 0.010 |
Why?
|
Sensitivity and Specificity | 1 | 2001 | 14720 | 0.000 |
Why?
|
Aged, 80 and over | 1 | 2010 | 57683 | 0.000 |
Why?
|
Postoperative Complications | 1 | 2007 | 15244 | 0.000 |
Why?
|